BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30919362)

  • 21. BRET approaches to characterize dopamine and TAAR1 receptor pharmacology and signaling.
    Espinoza S; Masri B; Salahpour A; Gainetdinov RR
    Methods Mol Biol; 2013; 964():107-22. PubMed ID: 23296781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Arrestin Recruitment to Chemokine Receptors by Bioluminescence Resonance Energy Transfer.
    Bonneterre J; Montpas N; Boularan C; Galés C; Heveker N
    Methods Enzymol; 2016; 570():131-53. PubMed ID: 26921945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioluminescence Resonance Energy Transfer (BRET)-Based Synthetic Sensor Platform for Drug Discovery.
    Woo J; Hong J; Dinesh-Kumar SP
    Curr Protoc Protein Sci; 2017 Apr; 88():19.30.1-19.30.12. PubMed ID: 28369669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved donor/acceptor BRET couples for monitoring beta-arrestin recruitment to G protein-coupled receptors.
    Kamal M; Marquez M; Vauthier V; Leloire A; Froguel P; Jockers R; Couturier C
    Biotechnol J; 2009 Sep; 4(9):1337-44. PubMed ID: 19557797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-Cell Arrestin-Receptor Interaction Assays.
    Zheng C; Javitch JA; Lambert NA; Donthamsetti P; Gurevich VV
    Curr Protoc; 2023 Oct; 3(10):e890. PubMed ID: 37787634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced BRET Technology for the Monitoring of Agonist-Induced and Agonist-Independent Interactions between GPCRs and β-Arrestins.
    Kocan M; Dalrymple MB; Seeber RM; Feldman BJ; Pfleger KD
    Front Endocrinol (Lausanne); 2010; 1():12. PubMed ID: 22654789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of key phosphorylation sites in PTH1R that determine arrestin3 binding and fine-tune receptor signaling.
    Zindel D; Engel S; Bottrill AR; Pin JP; Prézeau L; Tobin AB; Bünemann M; Krasel C; Butcher AJ
    Biochem J; 2016 Nov; 473(22):4173-4192. PubMed ID: 27623777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of enhanced bioluminescence energy transfer donors for protease biosensors.
    Dacres H; Michie M; Trowell SC
    Anal Biochem; 2012 May; 424(2):206-10. PubMed ID: 22387387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of BRET to Measure β-Arrestin Recruitment at Oxytocin and Vasopressin Receptors.
    Muratspahić E; Gattringer J; Gruber CW
    Methods Mol Biol; 2022; 2384():221-229. PubMed ID: 34550577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid kinetic BRET measurements to monitor G protein activation by GPCR and non-GPCR proteins.
    Maziarz M; Garcia-Marcos M
    Methods Cell Biol; 2017; 142():145-157. PubMed ID: 28964333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring Recruitment of β-Arrestin to G Protein-Coupled Heterodimers Using Bioluminescence Resonance Energy Transfer.
    Fillion D; Devost D; Hébert TE
    Methods Mol Biol; 2019; 1957():83-91. PubMed ID: 30919348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The BRET2/arrestin assay in stable recombinant cells: a platform to screen for compounds that interact with G protein-coupled receptors (GPCRS).
    Bertrand L; Parent S; Caron M; Legault M; Joly E; Angers S; Bouvier M; Brown M; Houle B; Ménard L
    J Recept Signal Transduct Res; 2002; 22(1-4):533-41. PubMed ID: 12503639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioluminescence Resonance Energy Transfer Approaches to Discover Bias in GPCR Signaling.
    Johnstone EK; Pfleger KD
    Methods Mol Biol; 2015; 1335():191-204. PubMed ID: 26260602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies.
    Granier S; Kim S; Shafer AM; Ratnala VR; Fung JJ; Zare RN; Kobilka B
    J Biol Chem; 2007 May; 282(18):13895-905. PubMed ID: 17347144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring NLR Oligomerization III: Detection of NLRP3 Complex by Bioluminescence Resonance Energy Transfer.
    Martín-Sánchez F; Compan V; Pelegrín P
    Methods Mol Biol; 2016; 1417():159-68. PubMed ID: 27221488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioluminescence resonance energy transfer (BRET) to detect the interactions between kappa opioid receptor and non visual arrestins.
    Bedini A
    Methods Mol Biol; 2015; 1230():115-28. PubMed ID: 25293320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRET: NanoLuc-Based Bioluminescence Resonance Energy Transfer Platform to Monitor Protein-Protein Interactions in Live Cells.
    Mo XL; Fu H
    Methods Mol Biol; 2016; 1439():263-71. PubMed ID: 27317001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of BRET to Study Protein-Protein Interactions In Vitro and In Vivo.
    Dimri S; Basu S; De A
    Methods Mol Biol; 2016; 1443():57-78. PubMed ID: 27246334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of GPCR-protein interactions by BRET.
    Kocan M; Pfleger KD
    Methods Mol Biol; 2011; 746():357-71. PubMed ID: 21607868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GPCR-Gα protein precoupling: Interaction between Ste2p, a yeast GPCR, and Gpa1p, its Gα protein, is formed before ligand binding via the Ste2p C-terminal domain and the Gpa1p N-terminal domain.
    Cevheroğlu O; Becker JM; Son ÇD
    Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2435-2446. PubMed ID: 28958779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.